Press Releases

CD Formulation's Scientists Share A Holistic Approach on How to Prepare Drug Microcapsules

CD Genomics Revolutionizes TCR-Seq Elevating Immune Repertoire Profiling to New Heights

CD Genomics Unveils Cutting-Edge CRISPR Screen Sequencing Technology

CD Genomics Introduces Cutting-Edge Degradome Sequencing Service Redefining Transcriptomics Research

JPA HEALTH EXPANDS LIFE SCIENCES DIVISION WITH ACQUISITION OF TRUE NORTH SOLUTIONS, INC.

Addition brings together synchronized experts to offer comprehensive predictive analytics, data visualization and AI-driven end-to-end solutions for life sciences, government and non-profit organizations

Inizio Engage launches new global powerhouse learning brand, Nazaré

Biotium Introduces New Highly-Selective Stains For Both Gram-Positive and Gram-Negative Bacteria

Biotium has announced the launch of its breakthrough BactoView™ Dead Stains and BactoView™ Viability Kits.

Quotient Sciences Appoints Thierry Van Nieuwenhove as New CEO

Avania Bolsters MedTech CRO Value Chain Capabilities With Two Acquisitions in Highly Strategic Areas of Engineering Design & Product Development and Market Access

Avania, a leading, global medical technology contract research organization (CRO), today announced its acquisition of HULL ASSOCIATES LLC and Ironstone Product Development (IPD) with a view toward addressing MedTech’s emerging priorities in regulatory and reimbursement and building scale to offer thoughtful strategies and differentiated project delivery for all product categories.

Expanding Research Horizons: CD Formulation Unveils its Redesigned Collection of Pharmaceutical Excipients

Unleashing Diamond's Full Potential: Alfa Chemistry's Single Crystalline and Polycrystalline Diamond Transformations

Mundipharma and Cidara Therapeutics receive positive CHMP opinion for rezafungin for the treatment of Invasive Candidiasis in adults

Mundipharma and Cidara Therapeutics receive positive CHMP opinion for rezafungin for the treatment of Invasive Candidiasis in adults. The opinion was based on positive results from the pivotal ReSTORE Phase III clinical trial and supported by the STRIVE Phase II clinical trials and extensive nonclinical development program.2,3 If approved by the European Medicines Agency, rezafungin could be the first new treatment option in over 10 years for patients with invasive candidiasis.4

WCG Raises the Bar in Quality Management Standards, Becoming ISO 9001 Certified in both IRB and IBC

WCG has now achieved ISO 9001 certification for its Institutional Biosafety Committee (IBC) services as well as its Institutional Review Board (IRB) services, emphasizing its commitment to excellence in quality management across ethical review.

Pioneering AI solutions and a commitment to industry-wide RBQM advancement secures CluePoints a finalist position in the 2023 SCRIP Awards

Pioneering AI solutions and a commitment to industry-wide RBQM advancement secures CluePoints a finalist position in the 2023 SCRIP Awards RBQM leader recognized in Specialist Providers Category at Citeline’s SCRIP Awards

Innovative Synthetic Fibers Released by Alfa Chemistry: Discover Carbon, Ceramic, Glass, and Polymer Options

Biopharma PEG: Your Premier Source for High-Purity Monodispersed PEGs

Biopharma PEG announces a robust inventory of monodispersed PEGs, including mPEG36-NH2, NH2-PEG24-COOH, and more, catering to the pharmaceutical industry's diverse needs. These high-purity products, certified under EXCIPACT GMP standards with purity exceeding 95%, are ideal for ADCs, PROTACs, and drug delivery systems, reinforcing Biopharma PEG as a top-tier provider for pharmaceutical researchers and developers.

Huateng Pharma Launches Gastrointestinal API Intermediates: Fexuprazan and Vonoprazan Intermediates

Huateng Pharma, a leading pharmaceutical ingredient manufacturer, has introduced a new product line, Gastrointestinal API Intermediates, featuring Fexuprazan and Vonoprazan Intermediates. These intermediates are designed to meet the increasing demand for high-quality solutions in gastrointestinal therapy. The products are available in both GMP and Non-GMP grades, boasting exceptional purity to facilitate the production of top-tier pharmaceuticals.

AES Clean Technology’s clients double down on ISPE Facility of the Year Awards (FOYA)

Headlands Research Continues Accelerated Growth with the Acquisition of Clinical Research Professionals, Further Expanding its Geographic Reach

Headlands Research adds fifth new clinical research site of 2023 with the acquisition of Clinical Research Professionals, which specializes in multiple therapeutic areas, including gastroenterology, neurology, and vaccines.

DLOC Biosystems chooses Discovery Park for new biology facility to develop organ-on-a-chip technology

DLOC Biosystems has selected Discovery Park, Kent, as the location for its new biology facility. The company will set up a biology lab within Discovery Park’s thriving life science cluster to continue development of its state-of-the-art organ-on-a-chip technology and deliver accurate assay testing services to pharmaceutical companies to advance drug discovery.